Physician profile

Bassem M Chehab

Cardiovascular Disease · Wichita, KS

NPI 1710006820

$481,668.08

in general payments reported to CMS, 2019-2025

34 companies · $89K in 2025

The $89K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

Payments by year

General and research payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$193,250.40
Travel and Lodging$28,083.54
Food and Beverage$21,776.53
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program$10,312.50
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$8,487.50
Entertainment$100.50

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $267,888.68 2019-2025 Mitraclip, Navitor, Tendyne
Edwards Lifesciences Corporation $137,264.00 2019-2025 Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Pascal
Biosense Webster, INC. $31,373.89 2023-2025 Carto 3, Nuvision Ice Catheter, Thermocool Sf
Medtronic, INC. $12,575.92 2021-2025 Corevalve Evolut R, Micra, Symplicity G3
Abiomed $10,668.20 2019-2025 Impella
Ancora Heart, INC. $3,702.18 2023-2024 Accucinch
Cardiva Medical, INC. $2,978.37 2024-2025 Savvywire, Other, Cardiva Vascade Mvp Xl Vvcs 10-12f
Recor Medical INC $2,587.57 2024-2025 Paradise Ultrasound Renal Denervation System, Paradise Renal Denervation System
Opsens INC. $2,200.50 2023 Savvywire, Optowire
Boston Scientific Corporation $1,932.69 2019-2021
Biotronik INC. $1,911.91 2019-2025 Orsiro Mission
Ge Healthcare $1,305.55 2022-2024
Cathworks, INC. $1,000.00 2024 Ffrangio
Medtronic Vascular, INC. $850.00 2020
Teleflex LLC $811.74 2025 Manta, Guideliner
Show all 32 companies
CompanyGeneral paymentsYearsTop products
Cardiovascular Systems INC. $472.78 2020-2022
Croivalve INC $388.31 2023-2024
Potrero Medical, INC. $379.19 2024-2025
Neovasc Medical INC $376.59 2021-2022
Cvrx, INC. $288.22 2023-2024 Barostim Neo System
Surmodics, INC. $142.42 2023 Pounce Thrombectomy, Pounce Venous Thrombectomy System, Pounce Thrombectomy System
Inari Medical, INC. $119.67 2021
Shockwave Medical, INC $115.28 2021-2025 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Cordis US Corp. $109.87 2024 Tempo Aqua
Procyrion, INC. $104.89 2023 Aortix System
Novo Nordisk INC $21.21 2024 Wegovy
Philips North America LLC $20.72 2025 Coronary Other
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $18.83 2024 Lifevest
Amgen INC. $18.10 2019
Kestra Medical Technology Services, INC. $16.81 2025 Assure Wcd
Penumbra, INC. $12.00 2022
Pfizer INC. $11.99 2022

2 companies reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

Research and ownership

$1,000.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Bassem M Chehab

$481,668.08

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbott Laboratories
Context
The $89K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/725450/bassem-m-chehab

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.